BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21119261)

  • 21. Multifocal electroretinography, color discrimination and ocular toxicity in tamoxifen use.
    Salomão SR; Watanabe SE; Berezovsky A; Motono M
    Curr Eye Res; 2007 Apr; 32(4):345-52. PubMed ID: 17453956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tamoxifen retinopathy. A case report.
    Costa RH; Dhooge MR; Van Wing F; De Rouck AF
    Bull Soc Belge Ophtalmol; 1990; 238():161-8. PubMed ID: 2131119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histopathologic behavior of endometrial hyperplasia during tamoxifen therapy for breast cancer.
    Garuti G; Cellani F; Centinaio G; Sita G; Nalli G; Luerti M
    Gynecol Oncol; 2006 May; 101(2):269-73. PubMed ID: 16297970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Optical coherence tomography study in tamoxifen maculopathy].
    Baget-Bernaldiz M; Soler Lluis N; Romero-Aroca P; Traveset-Maeso A
    Arch Soc Esp Oftalmol; 2008 Oct; 83(10):615-8. PubMed ID: 18855282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
    Sinawat S; Chiyabutra T; Kleabkaew P
    J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian cysts in tamoxifen-treated women with breast cancer.
    Inal MM; Incebiyik A; Sanci M; Yildirim Y; Polat M; Pilanci B; Nayki C; Camuzcuoğlu H
    Eur J Obstet Gynecol Reprod Biol; 2005 May; 120(1):104-6. PubMed ID: 15866095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant mixed mesodermal tumor after tamoxifen therapy for breast cancer.
    Hubalek M; Ramoni A; Mueller-Holzner E; Marth C
    Gynecol Oncol; 2004 Oct; 95(1):264-6. PubMed ID: 15385144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aromatase inhibitor-associated arthralgia syndrome.
    Burstein HJ
    Breast; 2007 Jun; 16(3):223-34. PubMed ID: 17368903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tamoxifen for breast cancer.
    Karn A; Jha AK; Shrestha S; Acharya B; Poudel S; Bhandari RB
    JNMA J Nepal Med Assoc; 2010; 49(177):62-7. PubMed ID: 21180225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stroke risk and tamoxifen therapy for breast cancer.
    Geiger AM; Fischberg GM; Chen W; Bernstein L
    J Natl Cancer Inst; 2004 Oct; 96(20):1528-36. PubMed ID: 15494603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
    Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
    J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Occlusion of finger arteries and thrombotic angiopathy of the retina during adjuvant tamoxifen therapy of a mammary carcinoma].
    Schlich B; Heidrich H; Keuch R; Bleckmann H
    Dtsch Med Wochenschr; 1997 Jun; 122(24):783-6. PubMed ID: 9229561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.
    ; Thürlimann B; Keshaviah A; Coates AS; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Rabaglio M; Smith I; Wardley A; Price KN; Goldhirsch A
    N Engl J Med; 2005 Dec; 353(26):2747-57. PubMed ID: 16382061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen deprivation therapy and colon cancer risk in breast cancer patients.
    Malaka DO; Olopade OI
    Breast J; 2010; 16(1):110-2. PubMed ID: 19929891
    [No Abstract]   [Full Text] [Related]  

  • 36. Exacerbation of endometriosis as a result of premenopausal tamoxifen exposure.
    Rose PG; Alvarez B; Maclennan GT
    Am J Obstet Gynecol; 2000 Aug; 183(2):507-8. PubMed ID: 10942499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pseudocystic foveal cavitation in tamoxifen retinopathy.
    Doshi RR; Fortun JA; Kim BT; Dubovy SR; Rosenfeld PJ
    Am J Ophthalmol; 2014 Jun; 157(6):1291-1298.e3. PubMed ID: 24582991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tamoxifen treatment and new-onset depression in breast cancer patients.
    Lee KC; Ray GT; Hunkeler EM; Finley PR
    Psychosomatics; 2007; 48(3):205-10. PubMed ID: 17478588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
    Swerdlow AJ; Jones ME;
    J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma.
    Katase K; Sugiyama Y; Hasumi K; Yoshimoto M; Kasumi F
    Cancer; 1998 May; 82(9):1698-703. PubMed ID: 9576291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.